Amarin Corp Plc (AMRN)

[jessellivermore]

Amarin as a long term position....

It comes down to "Enterprise Value" and the asymmetry of the bet...Simply put...What is the company worth and how risky is holding the stock..Amarin is a drug company with one drug...The rules do not really apply to Vascepa because it is more of an essential ingredient than a treatment for a single indication...In evaluating the company it is important to remember Vascepa is marketed and sold in many locales..Such as the USA and Europe...and has to the potential to be sold in many other locales and Amarin is currently valued mainly on its value in the USA and for limited indications...And it is not even the case that generics will be able to sell the drug for the all important CVD event reduction indication...

The first point being that all this local litigation does not threaten the companies right to sell the drug for all known proven remedies. The litigation is far more germane to the generics..The case being they have temporarily won the right to sell purified EPA for the very high trig indication. And this is not even uncontested as Generic Lovaza has an identical FDA label and is cheaper than generic VASCEPA. by all accounts Europe does not have our convoluted FDA situation and we do not have much concern over Vascepa's priority in the European market..(And Europe is a bigger market than the USA)...The point is the generic issue is not an issue in Europe...As most of you understand..Vascepa is a lifelong drug..

There are other markets..China...The middle East, Australia., South America, Canada, Africa... The sum total which dwarf the USA...Vascepa has a world wide market that is too large for most imaginations. Big enough if we lose some locales we are not going to go broke..Think of Vascepa as the British Empire at the time of Victoria..Do you really think the dubious loss of one of V's indications means the end of the Empire? The Company selling in single digits..is a joke..

There is no downside here...just time for things to happen and that is where the company's management and we shareholders need to focus our attentions..The thing here is patience...and not panic...

":>) JL